Last update 21 Nov 2024

Levodropropizine/GUAIFENESIN

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target-
Mechanism
Neuropeptides modulators(Neuropeptides modulators)
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication
Acute BronchitisAcute upper respiratory infectionBronchitis, Chronic+ [1]
Inactive Indication-
Originator Organization
Hunan Jiudian Pharmaceutical Co., Ltd.Hunan Jiudian Pharmaceutical Co., Ltd.
Active Organization
Hunan Jiudian Pharmaceutical Co., Ltd.Hunan Jiudian Pharmaceutical Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC10H14O4
InChIKeyHSRJKNPTNIJEKV-UHFFFAOYSA-N
CAS Registry93-14-1
View All Structures (2)

Related

1
Clinical Trials associated with Levodropropizine/GUAIFENESIN
CTR20220782
/ Not yet recruitingPhase 1
左羟愈酚胶囊中愈创木酚甘油醚与左羟丙哌嗪两活性成分在中国成年健康志愿者中稳态下药物间相互作用研究
[Translation] Study on the drug-drug interaction between the two active ingredients of guaifenesin and levopropion in levopropion capsules at steady state in Chinese adult healthy volunteers
100 Clinical Results associated with Levodropropizine/GUAIFENESIN
Login to view more data
100 Translational Medicine associated with Levodropropizine/GUAIFENESIN
Login to view more data
100 Patents (Medical) associated with Levodropropizine/GUAIFENESIN
Login to view more data
100 Deals associated with Levodropropizine/GUAIFENESIN
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute BronchitisPhase 1
CN
Hunan Jiudian Pharmaceutical Co., Ltd.Hunan Jiudian Pharmaceutical Co., Ltd.
08 Apr 2022
Acute upper respiratory infectionPhase 1
CN
Hunan Jiudian Pharmaceutical Co., Ltd.Hunan Jiudian Pharmaceutical Co., Ltd.
08 Apr 2022
Bronchitis, ChronicPhase 1
CN
Hunan Jiudian Pharmaceutical Co., Ltd.Hunan Jiudian Pharmaceutical Co., Ltd.
08 Apr 2022
CoughPhase 1
CN
Hunan Jiudian Pharmaceutical Co., Ltd.Hunan Jiudian Pharmaceutical Co., Ltd.
08 Apr 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free